Next Article in Journal
Compositional and in Vitro Evaluation of Nonwoven Type I Collagen/Poly-dl-lactic Acid Scaffolds for Bone Regeneration
Next Article in Special Issue
Peptide Amphiphiles in Corneal Tissue Engineering
Previous Article in Journal / Special Issue
Bioengineered Lacrimal Gland Organ Regeneration in Vivo
Article Menu

Export Article

Open AccessReview
J. Funct. Biomater. 2015, 6(3), 650-666;

Intraocular Implants for the Treatment of Autoimmune Uveitis

Department of Ophthalmology/Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI PA404, Oklahoma City, OK 73104, USA
Academic Editor: Dimitrios Karamichos
Received: 29 June 2015 / Revised: 21 July 2015 / Accepted: 27 July 2015 / Published: 31 July 2015
(This article belongs to the Special Issue Ocular Tissue Engineering)
Full-Text   |   PDF [212 KB, uploaded 31 July 2015]


Uveitis is the third leading cause of blindness in developed countries. Currently, the most widely used treatment of non-infectious uveitis is corticosteroids. Posterior uveitis and macular edema can be treated with intraocular injection of corticosteroids, however, this is problematic in chronic cases because of the need for repeat injections. Another option is systemic immunosuppressive therapies that have their own undesirable side effects. These systemic therapies result in a widespread suppression of the entire immune system, leaving the patient susceptible to infection. Therefore, an effective localized treatment option is preferred. With the recent advances in bioengineering, biodegradable polymers that allow for a slow sustained-release of a medication. These advances have culminated in drug delivery implants that are food and drug administration (FDA) approved for the treatment of non-infectious uveitis. In this review, we discuss the types of ocular implants available and some of the polymers used, implants used for the treatment of non-infectious uveitis, and bioengineered alternatives that are on the horizon. View Full-Text
Keywords: uveitis; non-infectious uveitis; intraocular implant; uveitis treatment; ocular drug delivery device uveitis; non-infectious uveitis; intraocular implant; uveitis treatment; ocular drug delivery device
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Printed Edition Available!
A printed edition of this Special Issue is available here.

Share & Cite This Article

MDPI and ACS Style

Lee, D.J. Intraocular Implants for the Treatment of Autoimmune Uveitis. J. Funct. Biomater. 2015, 6, 650-666.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Funct. Biomater. EISSN 2079-4983 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top